NorthWest Biotherapeutics Inc (NWBO)

[no2koolaid]

If DCVax is as good as we are led to believe, the question is what would be a realistic valuation of the company. Looking for a reasonable comparison, I used what Keytruda produced in its first seven years and did a set of DCF analyses, both conservative and not with a full Keytruda growth path. Admittedly, there is subjectivity...but the algorithm is the algorithm. Based on that, the projected share price was $21.29 for the very conservative estimate and $64.77 for the second.

The takeaway is that NWBO would have their own analyses done and have a basic idea of their value. But, realistically, it has to be more than $7-12.